Matthew R. Kwietniak, Chief Commercial Officer at Avid Bioservices, Inc. (CDMO), sold 255 shares at $9.19 ($2K) on 2023-10-12, disclosed to the SEC on 2023-10-13.
Open-market sale of $2k CDMO by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDMO | SELL | 2024-10-11 | $10K | — | Filing → |
| CDMO | SELL | 2024-07-16 | $3K | — | Filing → |
| CDMO | SELL | 2024-07-15 | $958 | — | Filing → |